Scientists track pregnancy outcomes years after RSV vaccination

NCT ID NCT05705440

Summary

This study followed people who had received an RSV vaccine or a placebo in earlier trials to see if the vaccine affected their health or their baby's health in pregnancies that happened later. It did not give any new treatments; it only collected safety information from over 3,800 participants for up to two years after their original vaccination. The goal was to understand the long-term safety of the RSV vaccine for future pregnancies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GSK Investigational Site

    Mobile, Alabama, 36608, United States

  • GSK Investigational Site

    Phoenix, Arizona, 85015, United States

  • GSK Investigational Site

    Tucson, Arizona, 85712, United States

  • GSK Investigational Site

    Burbank, California, 91506, United States

  • GSK Investigational Site

    Los Angeles, California, 90057, United States

  • GSK Investigational Site

    Nampa, Idaho, 83686, United States

  • GSK Investigational Site

    Nampa, Idaho, 83702, United States

  • GSK Investigational Site

    Covington, Louisiana, 70433, United States

  • GSK Investigational Site

    Slidell, Louisiana, 70458, United States

  • GSK Investigational Site

    Detroit, Michigan, 48201, United States

  • GSK Investigational Site

    Saginaw, Michigan, 48604, United States

  • GSK Investigational Site

    Biloxi, Mississippi, 39531, United States

  • GSK Investigational Site

    Albuquerque, New Mexico, 87107, United States

  • GSK Investigational Site

    Englewood, Ohio, 45322, United States

  • GSK Investigational Site

    Greenville, South Carolina, 29607, United States

  • GSK Investigational Site

    Hendersonville, Tennessee, 29708, United States

  • GSK Investigational Site

    Austin, Texas, 78705, United States

  • GSK Investigational Site

    Fort Worth, Texas, 76104, United States

  • GSK Investigational Site

    Houston, Texas, 77008, United States

  • GSK Investigational Site

    Keller, Texas, 76012, United States

  • GSK Investigational Site

    Keller, Texas, 76028, United States

  • GSK Investigational Site

    Keller, Texas, 76051, United States

  • GSK Investigational Site

    Lampasas, Texas, 76550, United States

  • GSK Investigational Site

    Plano, Texas, 75093, United States

  • GSK Investigational Site

    Weatherford, Texas, 76086, United States

  • GSK Investigational Site

    Norfolk, Virginia, 68701, United States

  • GSK Investigational Site

    Seattle, Washington, 98104, United States

  • GSK Investigational Site

    Buenos Aires, 1425, Argentina

  • GSK Investigational Site

    Córdoba, 5800, Argentina

  • GSK Investigational Site

    South Brisbane, Queensland, 4101, Australia

  • GSK Investigational Site

    Southport, Queensland, 4215, Australia

  • GSK Investigational Site

    Clayton, Victoria, 3168, Australia

  • GSK Investigational Site

    Matlab, Bangladesh

  • GSK Investigational Site

    Sylhet, 3100, Bangladesh

  • GSK Investigational Site

    Ghent, 9000, Belgium

  • GSK Investigational Site

    Leuven, 3000, Belgium

  • GSK Investigational Site

    Sint-Niklaas, 9100, Belgium

  • GSK Investigational Site

    Nova Iguaçu, 26030-380, Brazil

  • GSK Investigational Site

    Porto Alegre, 90035001, Brazil

  • GSK Investigational Site

    RibeirAo PretoSP, 14051-140, Brazil

  • GSK Investigational Site

    Santa Maria, 97105-900, Brazil

  • GSK Investigational Site

    São José do Rio Preto, 15090-000, Brazil

  • GSK Investigational Site

    Surrey, British Columbia, V3S 2N6, Canada

  • GSK Investigational Site

    Vancouver, British Columbia, V6Z 2T1, Canada

  • GSK Investigational Site

    Halifax, Nova Scotia, B3K 6R8, Canada

  • GSK Investigational Site

    Truro, Nova Scotia, B2N 1L2, Canada

  • GSK Investigational Site

    Kingston, Ontario, K7L 2V7, Canada

  • GSK Investigational Site

    London-Ontario, Ontario, N5W 6A2, Canada

  • GSK Investigational Site

    Sarnia, Ontario, N7T 4X3, Canada

  • GSK Investigational Site

    Toronto, Ontario, M9W 4L6, Canada

  • GSK Investigational Site

    Joliette, Quebec, J6E 6A9, Canada

  • GSK Investigational Site

    Montreal, Quebec, H3T 1C5, Canada

  • GSK Investigational Site

    Montreal, Quebec, H9R 4S3, Canada

  • GSK Investigational Site

    Montreal, Quebec, J7J 2K8, Canada

  • GSK Investigational Site

    Québec, Quebec, G1V 4G2, Canada

  • GSK Investigational Site

    Québec, Quebec, G1W 4R4, Canada

  • GSK Investigational Site

    Sherbrooke, Quebec, J1L 0H8, Canada

  • GSK Investigational Site

    Barranquilla, 760002, Colombia

  • GSK Investigational Site

    Cali Colombia, 760042, Colombia

  • GSK Investigational Site

    Chía, 250001, Colombia

  • GSK Investigational Site

    Medellín, 050034, Colombia

  • GSK Investigational Site

    Santo Domingo Este, Dominican Republic

  • GSK Investigational Site

    Espoo, 02230, Finland

  • GSK Investigational Site

    Helsinki, 00100, Finland

  • GSK Investigational Site

    Helsinki, 00290, Finland

  • GSK Investigational Site

    Helsinki, 00930, Finland

  • GSK Investigational Site

    Jarvenpaa, 04400, Finland

  • GSK Investigational Site

    Kokkola, 67100, Finland

  • GSK Investigational Site

    Oulu, 90220, Finland

  • GSK Investigational Site

    Pori, 28100, Finland

  • GSK Investigational Site

    Seinäjoki, 60100, Finland

  • GSK Investigational Site

    Tampere, 33100, Finland

  • GSK Investigational Site

    Turku, 20520, Finland

  • GSK Investigational Site

    Bordeaux, 33000, France

  • GSK Investigational Site

    Bron, 69500, France

  • GSK Investigational Site

    Paris, 75679, France

  • GSK Investigational Site

    Goch, 47574, Germany

  • GSK Investigational Site

    Hamburg, 22143, Germany

  • GSK Investigational Site

    Hanover, 30159, Germany

  • GSK Investigational Site

    Mainz, 55116, Germany

  • GSK Investigational Site

    Würzburg, 97070, Germany

  • GSK Investigational Site

    Comayagua, Honduras

  • GSK Investigational Site

    San Pedro Sula, 21101, Honduras

  • GSK Investigational Site

    Kolkata, 700017, India

  • GSK Investigational Site

    Mangalore, 575001, India

  • GSK Investigational Site

    Mysore, 570015, India

  • GSK Investigational Site

    Nagpur, 441108, India

  • GSK Investigational Site

    Pune, 411043, India

  • GSK Investigational Site

    Vadu Budruk Pune, 412216, India

  • GSK Investigational Site

    Bari, 70124, Italy

  • GSK Investigational Site

    Messina, 98124, Italy

  • GSK Investigational Site

    Milan, 20154, Italy

  • GSK Investigational Site

    Prato, 59100, Italy

  • GSK Investigational Site

    Grafton Auckland, 1010, New Zealand

  • GSK Investigational Site

    Papatoetoe Auckland, 1701, New Zealand

  • GSK Investigational Site

    Wellington, 6002, New Zealand

  • GSK Investigational Site

    Panama City, 07079, Panama

  • GSK Investigational Site

    Panama City, 0801, Panama

  • GSK Investigational Site

    Panama City, 1001, Panama

  • GSK Investigational Site

    Panama City, 7099, Panama

  • GSK Investigational Site

    Manila, 1000, Philippines

  • GSK Investigational Site

    Manila, 1008, Philippines

  • GSK Investigational Site

    Johannesburg, 2112, South Africa

  • GSK Investigational Site

    Pretoria, 0184, South Africa

  • GSK Investigational Site

    Soshanguve, 0152, South Africa

  • GSK Investigational Site

    Soweto Gauteng, 2013, South Africa

  • GSK Investigational Site

    Ansan, 425-707, South Korea

  • GSK Investigational Site

    Seoul, 08308, South Korea

  • GSK Investigational Site

    Seoul, South Korea

  • GSK Investigational Site

    Aravaca, 28023, Spain

  • GSK Investigational Site

    Barcelona, 08035, Spain

  • GSK Investigational Site

    Bilbao, 48013, Spain

  • GSK Investigational Site

    Boadilla Del Monte Madrid, 28660, Spain

  • GSK Investigational Site

    Burgos, 09006, Spain

  • GSK Investigational Site

    Getafe, 28905, Spain

  • GSK Investigational Site

    Madrid, 28006, Spain

  • GSK Investigational Site

    Madrid, 28007, Spain

  • GSK Investigational Site

    Madrid, 28034, Spain

  • GSK Investigational Site

    Madrid, 28041, Spain

  • GSK Investigational Site

    Madrid, 28046, Spain

  • GSK Investigational Site

    Madrid, 28222, Spain

  • GSK Investigational Site

    Madrid, 28400, Spain

  • GSK Investigational Site

    Marbella, 29603, Spain

  • GSK Investigational Site

    Málaga, 29004, Spain

  • GSK Investigational Site

    Santiago de Compostela, 15706, Spain

  • GSK Investigational Site

    Seville, 41013, Spain

  • GSK Investigational Site

    Seville, 41014, Spain

  • GSK Investigational Site

    TorrejOn Ardoz Madrid, 28850, Spain

  • GSK Investigational Site

    Valencia, 46017, Spain

  • GSK Investigational Site

    Valencia, 46020, Spain

  • GSK Investigational Site

    Valencia, 46702, Spain

  • GSK Investigational Site

    Valladolid, 47012, Spain

  • GSK Investigational Site

    Taichung, 40447, Taiwan

  • GSK Investigational Site

    Taipei, 0105, Taiwan

  • GSK Investigational Site

    Taipei, 10041, Taiwan

  • GSK Investigational Site

    Taoyuan District, 333, Taiwan

  • GSK Investigational Site

    Bangkok, 10330, Thailand

  • GSK Investigational Site

    Chiang Mai, 50200, Thailand

Conditions

Explore the condition pages connected to this study.